$KVA, KVB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in K-V Pharmaceutical Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in K-V Pharmaceutical Co. Get notifications about new insider transactions in K-V Pharmaceutical Co for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 21 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 10.01 | 500 | 5,003 | 14,337 | 13.8 K to 14.3 K (+3.61 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.75 | 100 | 2,375 | 1,373,690 | 1.4 M to 1.4 M (-0.01 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.40 | 14,800 | 346,320 | 1,373,790 | 1.4 M to 1.4 M (-1.07 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.65 | 600 | 14,190 | 1,388,590 | 1.4 M to 1.4 M (-0.04 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.64 | 100 | 2,364 | 1,389,190 | 1.4 M to 1.4 M (-0.01 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.63 | 2,600 | 61,438 | 1,389,290 | 1.4 M to 1.4 M (-0.19 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.62 | 400 | 9,448 | 1,391,890 | 1.4 M to 1.4 M (-0.03 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.61 | 4,300 | 101,523 | 1,392,290 | 1.4 M to 1.4 M (-0.31 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.60 | 3,600 | 84,960 | 1,396,590 | 1.4 M to 1.4 M (-0.26 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.59 | 500 | 11,795 | 1,400,190 | 1.4 M to 1.4 M (-0.04 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.58 | 300 | 7,074 | 1,400,690 | 1.4 M to 1.4 M (-0.02 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.57 | 1,300 | 30,641 | 1,400,990 | 1.4 M to 1.4 M (-0.09 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.56 | 3,900 | 91,884 | 1,402,290 | 1.4 M to 1.4 M (-0.28 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.55 | 900 | 21,195 | 1,406,190 | 1.4 M to 1.4 M (-0.06 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.53 | 300 | 7,059 | 1,407,090 | 1.4 M to 1.4 M (-0.02 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.52 | 11,900 | 279,888 | 1,407,390 | 1.4 M to 1.4 M (-0.84 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.50 | 200 | 4,700 | 1,419,290 | 1.4 M to 1.4 M (-0.01 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.49 | 1,000 | 23,490 | 1,419,490 | 1.4 M to 1.4 M (-0.07 %) |
Sep 18 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | S | 23.48 | 3,200 | 75,136 | 1,420,490 | 1.4 M to 1.4 M (-0.22 %) |
Jul 28 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Option Exercise | M | 12.50 | 96,450 | 1,205,914 | 0 | |
Jul 28 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Payment of Exercise | F | 18.01 | 66,959 | 1,205,932 | 118,677 | 185.6 K to 118.7 K (-36.07 %) |
Jul 28 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Buy | M | 12.50 | 96,450 | 1,205,914 | 1,316,613 | 1.2 M to 1.3 M (+7.90 %) |
Jul 06 2006 | KVA, KVB | K-V Pharmaceutical ... | Wenker Jerald J | President, Ther-Rx ... | Option Exercise | A | 18.66 | 10,000 | 186,600 | 10,000 | |
Apr 05 2006 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | M | 12.64 | 1,800 | 22,752 | 450 | |
Apr 05 2006 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | M | 10.84 | 11,250 | 121,939 | 0 | |
Apr 05 2006 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Buy | M | 12.64 | 1,800 | 22,752 | 13,050 | 11.3 K to 13.1 K (+16.00 %) |
Apr 05 2006 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Buy | M | 10.84 | 11,250 | 121,939 | 11,250 | 0 to 11.3 K |
Apr 07 2006 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Option Exercise | M | 12.10 | 5,250 | 63,525 | 0 | |
Apr 07 2006 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Buy | M | 12.10 | 5,250 | 63,525 | 15,375 | 10.1 K to 15.4 K (+51.85 %) |
Apr 04 2006 | KVA, KVB | K-V Pharmaceutical ... | McCullough Patricia K | CEO, ETHEX Corp. | Option Exercise | A | 24.12 | 50,000 | 1,206,000 | 50,000 | |
Apr 04 2006 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp VP-Indus Prese ... | Option Exercise | A | 24.12 | 75,000 | 1,809,000 | 75,000 | |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 10.21 | 2,700 | 27,572 | 10,800 | |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 6.79 | 788 | 5,347 | 2,363 | |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 3.45 | 1,013 | 3,495 | 0 | |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 10.01 | 2,700 | 27,014 | 10,800 | |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 10.21 | 2,700 | 27,572 | 2,700 | 0 to 2.7 K |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 6.79 | 788 | 5,347 | 13,837 | 13 K to 13.8 K (+6.04 %) |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 3.45 | 1,013 | 3,495 | 13,049 | 12 K to 13 K (+8.42 %) |
Mar 15 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 10.01 | 2,700 | 27,014 | 12,036 | 9.3 K to 12 K (+28.92 %) |
Mar 09 2006 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | M | 3.45 | 12,625 | 43,556 | 4,250 | |
Mar 09 2006 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | M | 2.36 | 12,375 | 29,156 | 0 | |
Mar 09 2006 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Buy | M | 3.45 | 12,625 | 43,556 | 29,000 | 16.4 K to 29 K (+77.10 %) |
Mar 09 2006 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Buy | M | 2.36 | 12,375 | 29,156 | 16,375 | 4 K to 16.4 K (+309.38 %) |
Feb 24 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | J | 0.00 | 35,141 | 0 | 1,349,072 | 1.4 M to 1.3 M (-2.54 %) |
Feb 24 2006 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 22.16 | 500 | 11,080 | 844 | 1.3 K to 844 (-37.20 %) |
Feb 24 2006 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 22.19 | 4,600 | 102,074 | 1,344 | 5.9 K to 1.3 K (-77.39 %) |
Feb 24 2006 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 22.23 | 432 | 9,603 | 5,944 | 6.4 K to 5.9 K (-6.78 %) |
Feb 21 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Option Exercise | C | 0.00 | 137,811 | 0 | 3,500 | |
Feb 21 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Buy | C | 0.00 | 137,811 | 0 | 166,686 | 28.9 K to 166.7 K (+477.27 %) |
Feb 21 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | C | 0.00 | 137,811 | 0 | 3,500 | 141.3 K to 3.5 K (-97.52 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.29 | 700 | 15,603 | 28,875 | 29.6 K to 28.9 K (-2.37 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.28 | 3,900 | 86,892 | 29,575 | 33.5 K to 29.6 K (-11.65 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.27 | 2,700 | 60,129 | 33,475 | 36.2 K to 33.5 K (-7.46 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.26 | 1,500 | 33,390 | 36,175 | 37.7 K to 36.2 K (-3.98 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.25 | 600 | 13,350 | 37,675 | 38.3 K to 37.7 K (-1.57 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.24 | 800 | 17,792 | 38,275 | 39.1 K to 38.3 K (-2.05 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.23 | 1,200 | 26,676 | 39,075 | 40.3 K to 39.1 K (-2.98 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.22 | 600 | 13,332 | 40,275 | 40.9 K to 40.3 K (-1.47 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.21 | 2,700 | 59,967 | 40,875 | 43.6 K to 40.9 K (-6.20 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.20 | 73,996 | 1,642,711 | 43,575 | 117.6 K to 43.6 K (-62.94 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.19 | 3,700 | 82,103 | 117,571 | 121.3 K to 117.6 K (-3.05 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.18 | 800 | 17,744 | 121,271 | 122.1 K to 121.3 K (-0.66 %) |
Feb 14 2006 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr.. Vice Pres. & S ... | Sell | S | 22.17 | 5,400 | 119,718 | 122,071 | 127.5 K to 122.1 K (-4.24 %) |
Jan 24 2006 | KVA, KVB | K-V Pharmaceutical ... | CHIOSTRI RAYMOND F | VP; P - Particle Dy ... | Option Exercise | M | 11.01 | 1,500 | 16,509 | 0 | |
Jan 24 2006 | KVA, KVB | K-V Pharmaceutical ... | CHIOSTRI RAYMOND F | VP; P - Particle Dy ... | Buy | M | 11.01 | 1,500 | 16,509 | 28,875 | 27.4 K to 28.9 K (+5.48 %) |
Jan 04 2006 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | M | 4.45 | 1,710 | 7,611 | 7,240 | |
Jan 04 2006 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | M | 4.47 | 1,710 | 7,649 | 6,415 | |
Jan 04 2006 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Buy | M | 4.45 | 1,710 | 7,611 | 72,095 | 70.4 K to 72.1 K (+2.43 %) |
Jan 04 2006 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Buy | M | 4.43 | 1,710 | 7,580 | 32,900 | 31.2 K to 32.9 K (+5.48 %) |
Jan 04 2006 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Gift | G | 0.00 | 3,150 | 0 | 31,190 | 34.3 K to 31.2 K (-9.17 %) |
Jan 06 2006 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | CEO, Ther-RX Corpor ... | Sell | S | 21.49 | 100 | 2,149 | 44,725 | 44.8 K to 44.7 K (-0.22 %) |
Jan 06 2006 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | CEO, Ther-RX Corpor ... | Sell | S | 21.50 | 39,900 | 857,850 | 44,825 | 84.7 K to 44.8 K (-47.09 %) |
Jan 06 2006 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | CEO, Ther-RX Corpor ... | Buy | W | 0.00 | 113 | 0 | 84,725 | 84.6 K to 84.7 K (+0.13 %) |
Dec 30 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | J | 0.00 | 36,184 | 0 | 1,423,690 | 1.5 M to 1.4 M (-2.48 %) |
Dec 30 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | J | 0.00 | 35,599 | 0 | 1,384,213 | 1.4 M to 1.4 M (-2.51 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Gift | G | 0.00 | 18,336 | 0 | 1,220,163 | 1.2 M to 1.2 M (-1.48 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Buy | J | 0.00 | 18,353 | 0 | 185,636 | 167.3 K to 185.6 K (+10.97 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.60 | 4,900 | 105,840 | 1,419,812 | 1.4 M to 1.4 M (-0.34 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.59 | 1,300 | 28,067 | 1,424,712 | 1.4 M to 1.4 M (-0.09 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.58 | 500 | 10,790 | 1,426,012 | 1.4 M to 1.4 M (-0.04 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.57 | 2,600 | 56,082 | 1,426,512 | 1.4 M to 1.4 M (-0.18 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.56 | 700 | 15,092 | 1,429,112 | 1.4 M to 1.4 M (-0.05 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.55 | 1,300 | 28,015 | 1,429,812 | 1.4 M to 1.4 M (-0.09 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.54 | 400 | 8,616 | 1,431,112 | 1.4 M to 1.4 M (-0.03 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.53 | 3,000 | 64,590 | 1,431,512 | 1.4 M to 1.4 M (-0.21 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.52 | 900 | 19,368 | 1,434,512 | 1.4 M to 1.4 M (-0.06 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.51 | 100 | 2,151 | 1,435,412 | 1.4 M to 1.4 M (-0.01 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.50 | 8,900 | 191,350 | 1,435,512 | 1.4 M to 1.4 M (-0.62 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.45 | 200 | 4,290 | 1,444,412 | 1.4 M to 1.4 M (-0.01 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.44 | 500 | 10,720 | 1,444,612 | 1.4 M to 1.4 M (-0.03 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.42 | 300 | 6,426 | 1,445,112 | 1.4 M to 1.4 M (-0.02 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.40 | 9,100 | 194,740 | 1,445,412 | 1.5 M to 1.4 M (-0.63 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.38 | 16,100 | 344,218 | 1,454,512 | 1.5 M to 1.5 M (-1.09 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.35 | 10,600 | 226,310 | 1,470,612 | 1.5 M to 1.5 M (-0.72 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.31 | 2,300 | 49,013 | 1,481,212 | 1.5 M to 1.5 M (-0.16 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.27 | 1,300 | 27,651 | 1,483,512 | 1.5 M to 1.5 M (-0.09 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.25 | 600 | 12,750 | 1,484,812 | 1.5 M to 1.5 M (-0.04 %) |
Dec 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 21.23 | 14,400 | 305,712 | 1,485,412 | 1.5 M to 1.5 M (-0.96 %) |
Nov 30 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 19.10 | 5,300 | 101,230 | 6,376 | 11.7 K to 6.4 K (-45.39 %) |
Nov 30 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 19.50 | 3,200 | 62,400 | 11,676 | 14.9 K to 11.7 K (-21.51 %) |
Nov 30 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 19.51 | 3,582 | 69,885 | 14,876 | 18.5 K to 14.9 K (-19.41 %) |
Nov 18 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Option Exercise | C | 0.00 | 83,882 | 0 | 0 | |
Nov 18 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | S | 19.40 | 93,000 | 1,804,200 | 0 | 93 K to 0 (-100.00 %) |
Nov 18 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | C | 0.00 | 83,882 | 0 | 94,896 | 178.8 K to 94.9 K (-46.92 %) |
Nov 18 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Buy | C | 0.00 | 83,882 | 0 | 93,000 | 9.1 K to 93 K (+919.96 %) |
Nov 16 2005 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 16.79 | 2,500 | 41,975 | 2,500 | |
Nov 15 2005 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 16.79 | 2,500 | 41,975 | 2,500 | |
Nov 15 2005 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | A | 16.79 | 10,000 | 167,900 | 10,000 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | Wenker Jerald J | President, Ther-Rx ... | Option Exercise | A | 16.79 | 30,000 | 503,700 | 30,000 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | Brady Paul T | President, PDI | Option Exercise | A | 16.79 | 20,000 | 335,800 | 20,000 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | A | 16.79 | 2,500 | 41,975 | 2,500 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 16.79 | 7,500 | 125,925 | 7,500 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Director | Option Exercise | A | 16.79 | 2,500 | 41,975 | 2,500 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | A | 16.79 | 25,000 | 419,750 | 25,000 | |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 19.98 | 585 | 11,688 | 18,458 | 19 K to 18.5 K (-3.07 %) |
Nov 14 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Sell | S | 19.94 | 2,800 | 55,832 | 19,043 | 21.8 K to 19 K (-12.82 %) |
Sep 07 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Option Exercise | M | 2.15 | 506 | 1,089 | 0 | |
Sep 07 2005 | KVA, KVB | K-V Pharmaceutical ... | Vogt Philip J | President, Ethex Co ... | Buy | M | 2.15 | 506 | 1,089 | 21,843 | 21.3 K to 21.8 K (+2.37 %) |
Aug 31 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | S | 17.07 | 600 | 10,242 | 9,118 | 9.7 K to 9.1 K (-6.17 %) |
Aug 31 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | S | 17.00 | 133,400 | 2,267,800 | 9,718 | 143.1 K to 9.7 K (-93.21 %) |
Aug 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | S | 16.85 | 44,100 | 743,085 | 143,118 | 187.2 K to 143.1 K (-23.56 %) |
Aug 16 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | S | 16.85 | 9,900 | 166,815 | 187,218 | 197.1 K to 187.2 K (-5.02 %) |
Aug 03 2005 | KVA, KVB | K-V Pharmaceutical ... | Wenker Jerald J | President, Ther-Rx ... | Option Exercise | M | 16.75 | 10,000 | 167,500 | 0 | |
Jul 18 2005 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Sell | S | 16.19 | 2,850 | 46,142 | 4,000 | 6.9 K to 4 K (-41.61 %) |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Option Exercise | C | 0.00 | 185,000 | 0 | 178,778 | |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Sell | C | 0.00 | 185,000 | 0 | 178,778 | 363.8 K to 178.8 K (-50.86 %) |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN VICTOR | Director | Buy | C | 0.00 | 185,000 | 0 | 197,118 | 12.1 K to 197.1 K (+1,526.65 %) |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 16.25 | 100 | 1,625 | 0 | 100 to 0 (-100.00 %) |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 16.70 | 1,400 | 23,380 | 100 | 1.5 K to 100 (-93.33 %) |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 16.86 | 1,000 | 16,860 | 1,500 | 2.5 K to 1.5 K (-40.00 %) |
Jun 27 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 16.89 | 1,000 | 16,890 | 2,500 | 3.5 K to 2.5 K (-28.57 %) |
Jun 24 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 17.50 | 1,750 | 30,625 | 3,500 | 5.3 K to 3.5 K (-33.33 %) |
Jun 24 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 17.40 | 400 | 6,960 | 5,250 | 5.7 K to 5.3 K (-7.08 %) |
Jun 24 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 17.45 | 700 | 12,215 | 5,650 | 6.4 K to 5.7 K (-11.02 %) |
Jun 24 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 17.59 | 300 | 5,277 | 6,350 | 6.7 K to 6.4 K (-4.51 %) |
Jun 24 2005 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Sell | S | 17.60 | 100 | 1,760 | 6,650 | 6.8 K to 6.7 K (-1.48 %) |
Feb 08 2005 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Sell | S | 20.46 | 250 | 5,115 | 130 | 380 to 130 (-65.79 %) |
Dec 22 2004 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Gift | G | 0.00 | 24,508 | 0 | 167,533 | 192 K to 167.5 K (-12.76 %) |
Dec 22 2004 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Vice Chairman, CEO | Buy | J | 0.00 | 24,508 | 0 | 0 | -24,508 to 0 (-100.00 %) |
Sep 24 2004 | KVA, KVB | K-V Pharmaceutical ... | ISAKSON JOHN P | Director | Option Exercise | M | 10.21 | 2,500 | 25,530 | 2,500 | |
Sep 14 2004 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Director | Option Exercise | A | 17.85 | 2,500 | 44,625 | 2,500 | |
Sep 14 2004 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | A | 17.85 | 2,500 | 44,625 | 2,500 | |
Sep 14 2004 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 17.85 | 2,500 | 44,625 | 2,500 | |
Sep 14 2004 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 17.85 | 2,500 | 44,625 | 2,500 | |
Sep 14 2004 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 17.85 | 2,500 | 44,625 | 2,500 | |
Sep 01 2004 | KVA, KVB | K-V Pharmaceutical ... | ISAKSON JOHN P | Director | Option Exercise | M | 10.21 | 2,500 | 25,530 | 5,000 | |
Aug 18 2004 | KVA, KVB | K-V Pharmaceutical ... | ISAKSON JOHN P | Director | Option Exercise | A | 15.31 | 5,000 | 76,550 | 5,000 | |
Aug 13 2004 | KVA, KVB | K-V Pharmaceutical ... | ISAKSON JOHN P | Director | Option Exercise | A | 16.53 | 2,000 | 33,060 | 2,000 | |
Jul 22 2004 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr. Vice Pres. & Se ... | Option Exercise | M | 7.04 | 33,678 | 236,925 | 0 | |
Jul 22 2004 | KVA, KVB | K-V Pharmaceutical ... | JOHNSON ALAN G | Sr. Vice Pres. & Se ... | Option Exercise | M | 7.04 | 15,386 | 108,241 | 0 |